Reiher L, Grabitz K, Sandmann W
Department of Vascular Surgery and Renal Transplantation, Heinrich Heine University, Düsseldorf, Germany.
Eur J Vasc Endovasc Surg. 2000 Nov;20(5):454-6. doi: 10.1053/ejvs.2000.1216.
many renal artery aneurysms (RAA) are diagnosed incidentally in the course of investigations for hypertension and their management is controversial.
to review the results of renal artery reconstruction for RAA.
between January 1978 and December 1998 111 RAR were performed in 81 kidneys in 71 patients.
fifty-nine patients were hypertensive, three had a creatinine >2.0 mg/dl and one was on dialysis. The principal underlying pathology was fibromuscular dysplasia (39) and atherosclerosis (17). The mean RAA diameter was 2.2 (range 1-15) cm overall and 3.5 (range 2-10) cm in four patients who presented with rupture. Fifty-one patients had renal artery stenosis. Autogenous material was used in 105 RAR. There was no 30-day mortality and the morbidity rate was 16%. The 5-year cumulative patency rate was 69%. Hypertension was cured in 25% and improved in 39%.
RAR tested for RAA treats hypertension and reduces the risk of rupture and distal embolisation.
许多肾动脉动脉瘤(RAA)在高血压调查过程中被偶然诊断出来,其治疗方法存在争议。
回顾肾动脉重建治疗RAA的结果。
1978年1月至1998年12月期间,对71例患者的81个肾脏进行了111例肾动脉重建术(RAR)。
59例患者患有高血压,3例肌酐>2.0mg/dl,1例接受透析治疗。主要潜在病理为纤维肌性发育不良(39例)和动脉粥样硬化(17例)。RAA的平均直径总体为2.2(范围1 - 15)cm,4例破裂患者的平均直径为3.5(范围2 - 10)cm。51例患者存在肾动脉狭窄。105例RAR使用了自体材料。30天内无死亡病例,发病率为16%。5年累积通畅率为69%。25%的高血压患者治愈,39%的患者病情改善。
RAR治疗RAA可治疗高血压并降低破裂和远端栓塞的风险。